StockNews.com assumed coverage on shares of Kamada (NASDAQ:KMDA – Get Rating) in a research report report published on Sunday morning. The brokerage issued a buy rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $11.00 price objective on shares of Kamada in a report on Thursday, March 16th. […]